FSH Regulates IGF-2 Expression in Human Granulosa Cells in an AKT-Dependent Manner.

CONTEXT IGF-2 is highly expressed in the granulosa cells of human dominant ovarian follicles; however, little is known about the regulation of the IGF-2 gene or the interaction of IGF-2 and FSH during follicle development. OBJECTIVE To examine the mechanisms involved in the regulation of the IGF-2 gene by FSH and the interplay between FSH and IGF-2 during granulosa cell differentiation. Design, Setting, Patients, and Interventions: Cumulus granulosa cells were separated from cumulus-oocyte complexes isolated from the follicular aspirates of in vitro fertilization patients and cultured for in vitro studies. MAIN OUTCOME Protein and mRNA levels of IGF-2 and CYP19A1 (aromatase) were quantified using Western blot and quantitative real-time PCR. IGF-2 promoter-specific activation was determined by the amplification of alternative exons by PCR. Cell proliferation was assessed after treatment with FSH and/or IGF-2. RESULTS FSH significantly enhanced IGF-2 expression after 8 hours of treatment and at low doses (1 ng/mL). Reciprocally, IGF-2 synergized with FSH to increase cell proliferation and the expression of CYP19A1. When IGF-2 activity was blocked, FSH was no longer able to stimulate CYP19A1 expression. Determination of IGF-2 promoter usage in human cumulus cells showed that the IGF-2 gene is driven by promoters P3 and P4. However, FSH exclusively increased P3 promoter-derived transcripts. Moreover, the FSH-induced stimulation of P3-driven IGF-2 transcripts was blocked by cotreatment with inhibitors of AKT or IGF-1 receptor (IGF-1R). The inhibitory effect of the IGF-1R inhibitor on FSH-induced IGF-2 mRNA accumulation was reversed by overexpression of a constitutively active AKT construct. CONCLUSIONS FSH is a potent enhancer of IGF-2 expression in human granulosa cells. In return, IGF-2 activation of the IGF-1R and AKT is required for FSH to stimulate CYP19A1 expression and proliferation of granulosa cells. These findings suggest a positive loop interaction between FSH and IGF-2 that is critical for human granulosa cell proliferation and differentiation.

[1]  B. Scoccia,et al.  IGF1R signaling is necessary for FSH-induced activation of AKT and differentiation of human Cumulus granulosa cells. , 2014, The Journal of clinical endocrinology and metabolism.

[2]  N. Winston,et al.  IGF-I signaling is essential for FSH stimulation of AKT and steroidogenic genes in granulosa cells. , 2013, Molecular endocrinology.

[3]  P. Humaidan,et al.  LH-receptor gene expression in human granulosa and cumulus cells from antral and preovulatory follicles. , 2012, The Journal of clinical endocrinology and metabolism.

[4]  L. Pal,et al.  Differential Granulosa Cell Gene Expression in Young Women with Diminished Ovarian Reserve , 2011, Reproductive Sciences.

[5]  J. Riedemann,et al.  IGF1R signalling and its inhibition. , 2006, Endocrine-related cancer.

[6]  Hsien-Ming Wu,et al.  Insulin-like growth factor-II (IGF-II), IGF-binding protein-3 (IGFBP-3), and IGFBP-4 in follicular fluid are associated with oocyte maturation and embryo development. , 2006, Fertility and sterility.

[7]  J. Rothstein,et al.  Regulation of astrocytic glutamate transporter expression by Akt: evidence for a selective transcriptional effect on the GLT‐1/EAAT2 subtype , 2006, Journal of neurochemistry.

[8]  D. Fabbro,et al.  In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase. , 2004, Cancer cell.

[9]  A. Zeleznik,et al.  Administration of insulin-like growth factor I to rhesus monkeys does not augment gonadotropin-stimulated ovarian steroidogenesis. , 2002, The Journal of clinical endocrinology and metabolism.

[10]  T. Ekström,et al.  GH is a regulator of IGF2 promoter-specific transcription in human liver. , 2002, The Journal of endocrinology.

[11]  L. Giudice,et al.  Ovarian follicular concentrations of activin, follistatin, inhibin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-2 (IGFBP-2), IGFBP-3, and vascular endothelial growth factor in spontaneous menstrual cycles of normal women of advanced reproductive age. , 2000, The Journal of clinical endocrinology and metabolism.

[12]  O. Hovatta,et al.  The effects of insulin, and insulin-like growth factors I and II on human ovarian follicles in long-term culture. , 2000, Molecular human reproduction.

[13]  R. Casamitjana,et al.  Growth hormone does not increase the expression of insulin-like growth factors and their receptor genes in the pre-menopausal human ovary. , 2000, Human reproduction.

[14]  M. Nisolle,et al.  Expression of receptors for insulin-like growth factor-I and transforming growth factor-beta in human follicles. , 2000, Molecular human reproduction.

[15]  A. Makrigiannakis,et al.  Insulin and insulin-like growth factor-I and -II modulate human granulosa-lutein cell steroidogenesis: enhancement of steroidogenic acute regulatory protein (StAR) expression. , 1999, Molecular human reproduction.

[16]  G. Cognigni,et al.  Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome. , 1999, The Journal of clinical endocrinology and metabolism.

[17]  L. Giudice,et al.  Insulin-like growth factor-II mediates the steroidogenic and growth promoting actions of follicle stimulating hormone on human ovarian pre-antral follicles cultured in vitro. , 1999, The Journal of clinical endocrinology and metabolism.

[18]  A. Gansmuller,et al.  Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  H. Mason,et al.  Developmentally regulated responses of human granulosa cells to insulin-like growth factors (IGFs): IGF-I and IGF-II action mediated via the type-I IGF receptor. , 1998, The Journal of clinical endocrinology and metabolism.

[20]  H. Osada,et al.  Altered transcriptional regulation of the insulin‐like growth factor 2 gene in human hepatocellular carcinoma , 1997, Molecular carcinogenesis.

[21]  M. Matzuk,et al.  Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility , 1997, Nature Genetics.

[22]  Z. Rosenwaks,et al.  Insulin-like growth factor II (IGF-II) inhibits insulin-like growth factor binding protein I (IGFBP-1) production in luteinized human granulosa cells with a potency similar to insulin-like growth factor I (IGF-I) and higher than insulin. , 1996, The Journal of clinical endocrinology and metabolism.

[23]  J. Baker,et al.  Effects of an Igf1 gene null mutation on mouse reproduction. , 1996, Molecular endocrinology.

[24]  L. Giudice,et al.  Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle. , 1996, The Journal of clinical endocrinology and metabolism.

[25]  C. Bondy,et al.  Granulosa cell DNA synthesis is strictly correlated with the presence of insulin-like growth factor I and absence of c-fos/c-jun expression. , 1995, Molecular endocrinology.

[26]  L. Giudice,et al.  Follicular fluid insulin-like growth factor-I and insulin-like growth factor-II concentrations vary as a function of day 3 serum follicle stimulating hormone. , 1995, Human reproduction.

[27]  H. Mason,et al.  Insulin preincubation enhances insulin-like growth factor-II (IGF-II) action on steroidogenesis in human granulosa cells. , 1994, The Journal of clinical endocrinology and metabolism.

[28]  A. Ferrari,et al.  Insulin-like growth factor-II stimulates human granulosa-luteal cell proliferation in vitro. , 1994, Fertility and sterility.

[29]  C. Roberts,et al.  Expression of insulin-like growth factor-I (IGF-I) and IGF-II and the IGF-I, IGF-II, and insulin receptor genes and localization of the gene products in the human ovary. , 1993, The Journal of clinical endocrinology and metabolism.

[30]  T. Aso,et al.  Insulin-like growth factor II in follicular fluid of the patients with in vitro fertilization and embryo transfer. , 1993, Fertility and sterility.

[31]  T. Aso,et al.  Effects of Insulin-Like Growth Factor-ll on Proliferation and Differentiation of Ovarian Granulosa Cells , 1992 .

[32]  L. Giudice,et al.  Insulin-like growth factor binding protein profiles in human ovarian follicular fluid correlate with follicular functional status. , 1992, The Journal of clinical endocrinology and metabolism.

[33]  L. Giudice,et al.  Follicular fluid insulin-like growth factor binding protein profiles in polycystic ovary syndrome. , 1992, The Journal of clinical endocrinology and metabolism.

[34]  T. Aso,et al.  Effects of insulin-like growth factor-II on proliferation and differentiation of ovarian granulosa cells. , 1992, Hormone Research.

[35]  J. Sussenbach,et al.  Structural and regulatory aspects of the human genes encoding IGF-I and -II. , 1991, Advances in experimental medicine and biology.

[36]  E. Adashi,et al.  Rat ovarian insulin-like growth factor I (IGF-I) gene expression is granulosa cell-selective: 5'-untranslated mRNA variant representation and hormonal regulation. , 1989, Endocrinology.

[37]  R. Voutilainen,et al.  Coordinate tropic hormone regulation of mRNAs for insulin-like growth factor II and the cholesterol side-chain-cleavage enzyme, P450scc [corrected], in human steroidogenic tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[38]  E. Adashi,et al.  Somatomedin-C-mediated potentiation of follicle-stimulating hormone-induced aromatase activity of cultured rat granulosa cells. , 1985, Endocrinology.

[39]  E. Adashi,et al.  Somatomedin-C enhances induction of luteinizing hormone receptors by follicle-stimulating hormone in cultured rat granulosa cells. , 1985, Endocrinology.

[40]  E. Adashi,et al.  Somatomedin-C synergizes with follicle-stimulating hormone in the acquisition of progestin biosynthetic capacity by cultured rat granulosa cells. , 1985, Endocrinology.